Since an elevated Treg/CD4+ ratio reflects enhanced immune tolerance and suppression of effector T cell proliferation, these findings may indicate an intrinsic immune dysregulation in RPL patients, as reported in reproductive and tumor immunology contexts47–50. This evidence concerns the gene CD4 and neoplasm.